{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:35:30Z","timestamp":1791279330133,"version":"4.1.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"1-2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.imlet.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,7,23]],"date-time":"2013-07-23T13:29:24Z","timestamp":1374586164000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Chloroquine: Modes of action of an undervalued drug"],"prefix":"10.1016","volume":"153","author":[{"given":"Rodolfo","family":"Thom\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie Costa Pinto","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Trindade Maranh\u00e3o","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Verinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2013.07.004_bib0005","series-title":"World Malaria Report 2011","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.imlet.2013.07.004_bib0010","doi-asserted-by":"crossref","first-page":"e1000402","DOI":"10.1371\/journal.pmed.1000402","article-title":"A research agenda for malaria eradication: drugs","volume":"8","year":"2011","journal-title":"PLoS Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.imlet.2013.07.004_bib0015","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.trstmh.2008.11.002","article-title":"The evolution of drug-resistant malaria","volume":"103","author":"Plowe","year":"2009","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00018-011-0906-0","article-title":"Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics","volume":"69","author":"Summers","year":"2012","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.imlet.2013.07.004_bib0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9343(99)80399-4","article-title":"A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study","volume":"98","year":"1995","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0030","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/art.21358","article-title":"Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus","volume":"52","author":"Bezerra","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.imlet.2013.07.004_bib0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/235050a0","article-title":"Lysosomes, pH and the anti-malarial action of chloroquine","volume":"235","author":"Homewood","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2013.07.004_bib0045","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0149-2918(96)80063-4","article-title":"Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine","volume":"18","author":"Chiang","year":"1996","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.imlet.2013.07.004_bib0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0149-2918(97)80045-8","article-title":"Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1","volume":"19","author":"Sperber","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.imlet.2013.07.004_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(83)91267-6","article-title":"Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy","volume":"75","author":"Bernstein","year":"1983","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0060","first-page":"415","article-title":"Chloroquine ocular toxicity","volume":"12","author":"Bernstein","year":"1967","journal-title":"Survey of Ophthalmology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(93)90056-J","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum","volume":"57","author":"Slater","year":"1993","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.imlet.2013.07.004_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4269\/ajtmh.1963.12.121","article-title":"Pitfalls in a discovery: the chronicle of chloroquine","volume":"12","author":"Coatney","year":"1963","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jama.1946.02870160015006","article-title":"Activity of a new antimalarial agent, chloroquine (SN 7618)","volume":"130","author":"Loeb","year":"1946","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.imlet.2013.07.004_bib0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(65)90395-8","article-title":"Chloroquine-resistant falciparum malaria in Thailand","volume":"2","author":"Harinasuta","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2013.07.004_bib0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.imlet.2013.07.004_bib0090","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1086\/375419","article-title":"Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi","volume":"187","author":"Kublin","year":"2003","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4269\/ajtmh.2003.68.413","article-title":"Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi","volume":"68","author":"Mita","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2875-8-106","article-title":"Chloroquine resistance before and after its withdrawal in Kenya","volume":"8","author":"Mwai","year":"2009","journal-title":"Malaria Journal"},{"key":"10.1016\/j.imlet.2013.07.004_bib0105","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa062032","article-title":"Return of chloroquine antimalarial efficacy in Malawi","volume":"355","author":"Laufer","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4269\/ajtmh.2012.11-0709","article-title":"Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal","volume":"87","author":"Ndiaye","year":"2012","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1475-2875-11-197","article-title":"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal","volume":"11","author":"Wurtz","year":"2012","journal-title":"Malaria Journal"},{"key":"10.1016\/j.imlet.2013.07.004_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1475-2875-12-35","article-title":"Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000\u20132011","volume":"12","author":"Gharbi","year":"2013","journal-title":"Malaria Journal"},{"key":"10.1016\/j.imlet.2013.07.004_bib0125","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/CMR.00008-09","article-title":"Resistance to therapies for infection by Plasmodium vivax","volume":"22","author":"Baird","year":"2009","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.imlet.2013.07.004_bib0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(89)91792-3","article-title":"Plasmodium vivax resistance to chloroquine","volume":"2","author":"Rieckmann","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2013.07.004_bib0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1590\/S0074-02762002000400020","article-title":"Assessment of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a Malaria transmission free area in Colombia","volume":"97","author":"Castillo","year":"2002","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.imlet.2013.07.004_bib0140","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4269\/ajtmh.2003.69.548","article-title":"Chloroquine-resistant Plasmodium vivax malaria in Peru","volume":"69","author":"Ruebush","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4269\/ajtmh.2001.65.90","article-title":"Plasmodium vivax clinically resistant to chloroquine in Colombia","volume":"65","author":"Soto","year":"2001","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0150","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.2003.68.416","article-title":"Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua","volume":"68","author":"Sumawinata","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.trstmh.2006.06.008","article-title":"Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia","volume":"101","author":"Ratcliff","year":"2007","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0160","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pmed.0050128","article-title":"Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia","volume":"5","author":"Tjitra","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0165","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0026-895X(25)09615-4","article-title":"Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum","volume":"50","author":"Bray","year":"1996","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.88.2.325","article-title":"An iron-carboxylate bond links the heme units of malaria pigment","volume":"88","author":"Slater","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imlet.2013.07.004_bib0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1083\/jcb.145.2.363","article-title":"Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum","volume":"145","author":"Bray","year":"1999","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.54.1.170","article-title":"Access to hematin: the basis of chloroquine resistance","volume":"54","author":"Bray","year":"1998","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35005132","article-title":"The structure of malaria pigment beta-haematin","volume":"404","author":"Pagola","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2013.07.004_bib0190","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.93.21.11865","article-title":"On the molecular mechanism of chloroquine's antimalarial action","volume":"93","author":"Sullivan","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imlet.2013.07.004_bib0195","doi-asserted-by":"crossref","first-page":"31103","DOI":"10.1074\/jbc.273.47.31103","article-title":"A common mechanism for blockade of heme polymerization by antimalarial quinolines","volume":"273","author":"Sullivan","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.imlet.2013.07.004_bib0200","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.21.5.819","article-title":"Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex","volume":"21","author":"Fitch","year":"1982","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.imlet.2013.07.004_bib0205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0006-2952(86)90345-X","article-title":"A perspective on antimalarial action: effects of weak bases on Plasmodium falciparum","volume":"35","author":"Krogstad","year":"1986","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0210","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1083\/jcb.101.6.2302","article-title":"Antimalarials increase vesicle pH in Plasmodium falciparum","volume":"101","author":"Krogstad","year":"1985","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1083\/jcb.140.2.335","article-title":"Differential stimulation of the Na+\/H+ exchanger determines chloroquine uptake in Plasmodium falciparum","volume":"140","author":"Wunsch","year":"1998","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0220","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1074\/jbc.272.5.2652","article-title":"Identification of a chloroquine importer in Plasmodium falciparum. Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype","volume":"272","author":"Sanchez","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.imlet.2013.07.004_bib0225","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1073\/pnas.64.4.1181","article-title":"Chloroquine resistance in malaria: a deficiency of chloroquine binding","volume":"64","author":"Fitch","year":"1969","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imlet.2013.07.004_bib0230","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.3317830","article-title":"Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance","volume":"238","author":"Krogstad","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.imlet.2013.07.004_bib0235","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Molecular Cell"},{"key":"10.1016\/j.imlet.2013.07.004_bib0240","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0854.2009.01018.x","article-title":"Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum","volume":"11","author":"Kuhn","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.imlet.2013.07.004_bib0245","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1038\/sj.emboj.7600681","article-title":"A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance","volume":"24","author":"Lakshmanan","year":"2005","journal-title":"EMBO Journal"},{"key":"10.1016\/j.imlet.2013.07.004_bib0250","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.1175667","article-title":"Chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"325","author":"Martin","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.imlet.2013.07.004_bib0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1054\/drup.2001.0183","article-title":"The ABC transporter genes of Plasmodium falciparum and drug resistance","volume":"4","author":"Peel","year":"2001","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"10.1016\/j.imlet.2013.07.004_bib0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actatropica.2005.04.008","article-title":"Contribution of the pfmdr1 gene to antimalarial drug-resistance","volume":"94","author":"Duraisingh","year":"2005","journal-title":"Acta Tropica"},{"key":"10.1016\/j.imlet.2013.07.004_bib0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM200101253440403","article-title":"A molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimde","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0270","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1086\/320195","article-title":"High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1","volume":"183","author":"Babiker","year":"2001","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0275","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182001008344","article-title":"Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria","volume":"123","author":"Adagu","year":"2001","journal-title":"Parasitology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0280","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1365-2958.2003.03627.x","article-title":"Multiple transporters associated with malaria parasite responses to chloroquine and quinine","volume":"49","author":"Mu","year":"2003","journal-title":"Molecular Microbiology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0285","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4269\/ajtmh.2003.68.350","article-title":"Analysis of pfcrt, pfmdr1, dhfr, and dhps mutations and drug sensitivities in Plasmodium falciparum isolates from patients in Vietnam before and after treatment with artemisinin","volume":"68","author":"Ngo","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0290","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0295","series-title":"Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000\u20132010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.imlet.2013.07.004_bib0300","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.3544220","article-title":"Reversal of chloroquine resistance in Plasmodium falciparum by verapamil","volume":"235","author":"Martin","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.imlet.2013.07.004_bib0305","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/QCO.0b013e3282f1673a","article-title":"Strategies to reverse drug resistance in malaria","volume":"20","author":"Egan","year":"2007","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0310","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/156720110793360577","article-title":"Chloroquine resistance: proposed mechanisms and countermeasures","volume":"7","author":"Guantai","year":"2010","journal-title":"Current Drug Delivery"},{"key":"10.1016\/j.imlet.2013.07.004_bib0315","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/AAC.00166-12","article-title":"Saquinavir inhibits the malaria parasite's chloroquine resistance transporter","volume":"56","author":"Martin","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.imlet.2013.07.004_bib0320","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.1996.55.579","article-title":"Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro","volume":"55","author":"De","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.imlet.2013.07.004_bib0325","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1128\/AAC.40.8.1846","article-title":"4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum","volume":"40","author":"Ridley","year":"1996","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.imlet.2013.07.004_bib0330","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm970401y","article-title":"antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue","volume":"40","author":"Biot","year":"1997","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.imlet.2013.07.004_bib0335","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1034\/j.1600-0463.2002.100606.x","article-title":"Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells","volume":"110","author":"Sundelin","year":"2002","journal-title":"APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica"},{"key":"10.1016\/j.imlet.2013.07.004_bib0340","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary. Lysosomotropic agents","volume":"23","author":"de Duve","year":"1974","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0345","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.imlet.2013.07.004_bib0350","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1083\/jcb.63.2.665","article-title":"Stability of DNA in Purkinje cell nuclei of the mouse. An autoradiographic study","volume":"63","author":"Mares","year":"1974","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0355","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0041-008X(65)90050-5","article-title":"Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats","volume":"7","author":"McChesney","year":"1965","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0360","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1083\/jcb.63.2.430","article-title":"Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1","volume":"63","author":"Wibo","year":"1974","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0365","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1074\/jbc.M113.457002","article-title":"Chloroquine binding reveals flavin redox switch function of quinone reductase 2","volume":"288","author":"Leung","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.imlet.2013.07.004_bib0370","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1158\/0008-5472.CAN-07-0323","article-title":"NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53","volume":"67","author":"Gong","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.imlet.2013.07.004_bib0375","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/bi035923w","article-title":"Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines","volume":"43","author":"Kwiek","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.imlet.2013.07.004_bib0380","doi-asserted-by":"crossref","first-page":"46131","DOI":"10.1074\/jbc.M208675200","article-title":"Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity","volume":"277","author":"Long","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.imlet.2013.07.004_bib0385","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1158\/0008-5472.CAN-07-2213","article-title":"Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases","volume":"67","author":"Ahn","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.imlet.2013.07.004_bib0390","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0395","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1096\/fj.03-0289fje","article-title":"Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration","volume":"18","author":"Bergmann","year":"2004","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0400","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/CVI.00166-08","article-title":"Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo","volume":"15","author":"Garulli","year":"2008","journal-title":"Clinical and Vaccine Immunology: CVI"},{"key":"10.1016\/j.imlet.2013.07.004_bib0405","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1357-2725(02)00384-9","article-title":"Neurodegeneration: linking ubiquitin\/proteasome pathway impairment with inflammation","volume":"35","author":"Li","year":"2003","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0410","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1073\/pnas.93.2.654","article-title":"Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification","volume":"93","author":"Gottlieb","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imlet.2013.07.004_bib0415","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1167\/iovs.10-5278","article-title":"Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells","volume":"51","author":"Yoon","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.imlet.2013.07.004_bib0420","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nrd2272","article-title":"Potential therapeutic applications of autophagy","volume":"6","author":"Rubinsztein","year":"2007","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.imlet.2013.07.004_bib0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/cdd.2008.130","article-title":"Eating the enemy within: autophagy in infectious diseases","volume":"16","author":"Orvedahl","year":"2009","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.imlet.2013.07.004_bib0430","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/AAC.00555-09","article-title":"Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent","volume":"53","author":"Chiu","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.imlet.2013.07.004_bib0435","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.imlet.2013.07.004_bib0440","doi-asserted-by":"crossref","first-page":"e47126","DOI":"10.1371\/journal.pone.0047126","article-title":"Autophagy creates a CTL epitope that mimics tumor-associated antigens","volume":"7","author":"Demachi-Okamura","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2013.07.004_bib0445","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","article-title":"Effector and memory CTL differentiation","volume":"25","author":"Williams","year":"2007","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0450","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatology and Therapy"},{"key":"10.1016\/j.imlet.2013.07.004_bib0455","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4049\/jimmunol.160.3.1122","article-title":"Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds","volume":"160","author":"Macfarlane","year":"1998","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0460","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.158.10.4901","article-title":"Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages","volume":"158","author":"Jeong","year":"1997","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0465","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0306-3623(97)00269-3","article-title":"Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis","volume":"30","author":"Bondeson","year":"1998","journal-title":"General Pharmacology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0470","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0475","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.0019-2805.2001.01339.x","article-title":"Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells","volume":"105","author":"Jeong","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0480","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0162-0134(02)00633-5","article-title":"Changes in function of iron-loaded alveolar macrophages after in vivo administration of desferrioxamine and\/or chloroquine","volume":"94","author":"Legssyer","year":"2003","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.imlet.2013.07.004_bib0485","first-page":"127","article-title":"Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism","volume":"80","author":"Picot","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0490","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.4049\/jimmunol.165.3.1534","article-title":"Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism","volume":"165","author":"Weber","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0495","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V95.11.3460","article-title":"Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties","volume":"95","author":"Goldman","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2013.07.004_bib0500","first-page":"803","article-title":"Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells","volume":"20","author":"Sperber","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0505","first-page":"R1058","article-title":"Chloroquine inhibits proinflammatory cytokine release into human whole blood","volume":"274","author":"Karres","year":"1998","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0510","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archsurg.1992.01420010084012","article-title":"Chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis","volume":"127","author":"Ertel","year":"1992","journal-title":"Archives of Surgery"},{"key":"10.1016\/j.imlet.2013.07.004_bib0515","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bcp.2011.11.022","article-title":"Akt and p53 are potential mediators of reduced mammary tumor growth by Chloroquine and the mTOR inhibitor RAD001","volume":"83","author":"Loehberg","year":"2012","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0520","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/aid.1993.9.91","article-title":"Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes","volume":"9","author":"Sperber","year":"1993","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.imlet.2013.07.004_bib0525","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.43.1.284-293.1982","article-title":"Infectious cell entry mechanism of influenza virus","volume":"43","author":"Yoshimura","year":"1982","journal-title":"Journal of Virology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0530","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1099\/0022-1317-64-5-1149","article-title":"Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine","volume":"64","author":"Shibata","year":"1983","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0535","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-3-39","article-title":"In vitro inhibition of human influenza A virus replication by chloroquine","volume":"3","author":"Ooi","year":"2006","journal-title":"Virology Journal"},{"key":"10.1016\/j.imlet.2013.07.004_bib0540","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-4-39","article-title":"Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses","volume":"4","author":"Di Trani","year":"2007","journal-title":"Virology Journal"},{"key":"10.1016\/j.imlet.2013.07.004_bib0545","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/JVI.01229-07","article-title":"Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells","volume":"82","author":"Misinzo","year":"2008","journal-title":"Journal of Virology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0550","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1517\/13543784.15.12.1507","article-title":"A historical sketch of the discovery and development of HIV-1 integrase inhibitors","volume":"15","author":"Savarino","year":"2006","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.imlet.2013.07.004_bib0555","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0149-2918(95)80039-5","article-title":"Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1","volume":"17","author":"Sperber","year":"1995","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.imlet.2013.07.004_bib0560","doi-asserted-by":"crossref","first-page":"12082","DOI":"10.1128\/JVI.01466-10","article-title":"Reduction of immune activation with chloroquine therapy during chronic HIV infection","volume":"84","author":"Murray","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0565","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2011-01-329060","article-title":"Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders","volume":"118","author":"Piconi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2013.07.004_bib0570","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood.V98.4.906","article-title":"Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients","volume":"98","author":"Soumelis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2013.07.004_bib0575","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/AAC.01246-09","article-title":"Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation","volume":"54","author":"Martinson","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.imlet.2013.07.004_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1996.1302","article-title":"Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine","volume":"226","author":"Jiang","year":"1996","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.imlet.2013.07.004_bib0585","doi-asserted-by":"crossref","first-page":"11440","DOI":"10.1128\/JVI.76.22.11440-11446.2002","article-title":"Inhibition of endosomal\/lysosomal degradation increases the infectivity of human immunodeficiency virus","volume":"76","author":"Fredericksen","year":"2002","journal-title":"Journal of Virology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0590","first-page":"2919","article-title":"Canadian Consensus Conference on hydroxychloroquine","volume":"27","author":"Canadian Rheumatology Association","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0595","first-page":"983","article-title":"Aspects of use of antimalarials in systemic lupus erythematosus","volume":"25","author":"Gladman","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0600","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0605","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","article-title":"Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology","volume":"44","author":"Tan","year":"1989","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0610","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0615","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2013.07.004_bib0620","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.21039","article-title":"Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual","volume":"52","author":"Fessler","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.imlet.2013.07.004_bib0625","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINAL)","volume":"66","author":"Alarcon","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0630","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2013.07.004_bib0635","first-page":"2142","article-title":"Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus","volume":"27","author":"Tam","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0640","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2013.07.004_bib0645","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2230.2008.03006.x","article-title":"Systematic administration of chloroquine in discoid lupus erythematosus reduces skin lesions via inhibition of angiogenesis","volume":"34","author":"Lesiak","year":"2009","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0650","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archdermatol.2008.592","article-title":"Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking","volume":"145","author":"Kreuter","year":"2009","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0655","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1346-8138.2011.01448.x","article-title":"Hydroxychloroquine administration for Japanese lupus erythematosus in Wakayama: a pilot study","volume":"39","author":"Ikeda","year":"2012","journal-title":"Journal of Dermatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0660","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2010.06.018","article-title":"Cutaneous lupus erythematosus: update of therapeutic options. Part I","volume":"65","author":"Kuhn","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0665","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/1346-8138.12005","article-title":"Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus","volume":"40","author":"Momose","year":"2013","journal-title":"Journal of Dermatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0670","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.imlet.2013.07.004_bib0675","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1590\/S0100-879X2008005000021","article-title":"A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies","volume":"41","author":"Louzada-Junior","year":"2008","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.imlet.2013.07.004_bib0680","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2011.04.021","article-title":"An overview on the genetic of rheumatoid arthritis: a never-ending story","volume":"10","author":"Perricone","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.imlet.2013.07.004_bib0685","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0765.2005.00814.x","article-title":"Inflammatory bone destruction and osteoimmunology","volume":"40","author":"Takayanagi","year":"2005","journal-title":"Journal of Periodontal Research"},{"key":"10.1016\/j.imlet.2013.07.004_bib0690","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/bbrc.1997.7404","article-title":"A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis","volume":"240","author":"Takayanagi","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.imlet.2013.07.004_bib0695","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/ard.2007.080341","article-title":"Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis","volume":"67","author":"Yamada","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0700","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20092301","article-title":"Complement drives Th17 cell differentiation and triggers autoimmune arthritis","volume":"207","author":"Hashimoto","year":"2009","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.imlet.2013.07.004_bib0705","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0710","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.1780331001","article-title":"The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses","volume":"33","author":"Felson","year":"1990","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.imlet.2013.07.004_bib0715","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/rheumatology\/28.2.128","article-title":"Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study","volume":"28","author":"Scott","year":"1989","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0720","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/jama.1982.03330140028027","article-title":"Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine","volume":"248","author":"McCarty","year":"1982","journal-title":"JAMA: Journal of the American Medical Association"},{"key":"10.1016\/j.imlet.2013.07.004_bib0725","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/art.1780270304","article-title":"Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis","volume":"27","author":"Bunch","year":"1984","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.imlet.2013.07.004_bib0730","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/rheumatology\/26.4.279","article-title":"D-penicillamine and chloroquine treatment of rheumatoid arthritis \u2013 a comparative study","volume":"26","author":"Gibson","year":"1987","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0735","doi-asserted-by":"crossref","first-page":"e65913","DOI":"10.1371\/journal.pone.0065913","article-title":"Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis","volume":"8","author":"Thome","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2013.07.004_bib0740","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10428199709039008","article-title":"The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease","volume":"24","author":"Schultz","year":"1997","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.imlet.2013.07.004_bib0745","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/bbmt.2002.v8.abbmt080648","article-title":"Chloroquine prevention of murine MHC-disparate acute graft-versus-host disease correlates with inhibition of splenic response to CpG oligodeoxynucleotides and alterations in T-cell cytokine production","volume":"8","author":"Schultz","year":"2002","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.imlet.2013.07.004_bib0750","first-page":"1069","article-title":"The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease","volume":"17","author":"Gilman","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.imlet.2013.07.004_bib0755","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1083-8791(00)70058-9","article-title":"Hydroxychloroquine for the treatment of chronic graft-versus-host disease","volume":"6","author":"Gilman","year":"2000","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.imlet.2013.07.004_bib0760","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood.V86.11.4344.bloodjournal86114344","article-title":"Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease","volume":"86","author":"Schultz","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2013.07.004_bib0765","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(59)90604-X","article-title":"Retinopathy following chloroquine therapy","volume":"2","author":"Hobbs","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2013.07.004_bib0770","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1590\/S0004-27492012000300004","article-title":"Amsler grid and visual field on screening for chloroquine retinopathy","volume":"75","author":"Madalena","year":"2012","journal-title":"Arquivos brasileiros de oftalmologia"},{"key":"10.1016\/j.imlet.2013.07.004_bib0775","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/art.1780400817","article-title":"Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice","volume":"40","author":"Levy","year":"1997","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.imlet.2013.07.004_bib0780","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0785","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0790","first-page":"629","article-title":"Localized scleroderma evolving into systemic sclerosis","volume":"12","author":"Rossi","year":"1985","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0795","first-page":"1726","article-title":"The blood\u2013retinal barrier in chloroquine retinopathy","volume":"30","author":"Raines","year":"1989","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.imlet.2013.07.004_bib0800","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.51.12.1318","article-title":"Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis","volume":"51","author":"Morand","year":"1992","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0805","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.56.3.188","article-title":"Hydroxychloroquine and visual screening in a rheumatology outpatient clinic","volume":"56","author":"Grierson","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.imlet.2013.07.004_bib0810","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0161-6420(03)00409-3","article-title":"The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal","volume":"110","author":"Mavrikakis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.imlet.2013.07.004_bib0815","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-3701-1-10","article-title":"Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration","volume":"1","author":"Chen","year":"2011","journal-title":"Cell & Bioscience"},{"key":"10.1016\/j.imlet.2013.07.004_bib0820","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02258379","article-title":"Lamp-1 is upregulated in human glioblastoma cell lines induced to undergo apoptosis","volume":"8","author":"Chen","year":"2001","journal-title":"Journal of Biomedical Science"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247813000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247813000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T09:22:56Z","timestamp":1746004976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247813000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":164,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0165247813000965"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2013.07.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chloroquine: Modes of action of an undervalued drug","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}